日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial

在中国晚期胰腺腺癌患者中，NALIRIFOX 对比吉西他滨联合白蛋白紫杉醇：一项随机、开放标签的 II 期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68409-0
Gao, Chuntao; Zhang, Yanqiao; Qu, Xiujuan; Chen, Xingyun; Zhang, Jingdong; Wu, Heshui; Sun, Meili; Zha, Yong; Wang, Junbin; Wang, Yusheng; Li, Zhihua; Gao, Jinghua; Lin, Rongbo; Zang, Aimin; Zhang, Huiqing; Yuan, Xianglin; Du, Chengyou; Zhao, Jun; Yang, Yongsheng; Shi, Xuetao; Cheng, Wei; Wang, Bangmao; Wu, Shikai; Zhao, Tiansuo; Wang, Jian; Gao, Song; Wang, Xiuchao; Ma, Weidong; Liu, Rui; Shi, Yehui; Liu, Yanping; Xie, Yijiao; Niu, Miao; Zhao, Fuchen; Yu, Jun; Hao, Jihui
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells.

伤害感受器神经元通过与癌症相关成纤维细胞相互作用和抑制自然杀伤细胞来促进 PDAC 进展和癌症疼痛

期刊:Cell Research
影响因子:25.9
doi:10.1038/s41422-025-01098-4
Wang Kaiyuan, Ni Bo, Xie Yongjie, Li Zekun, Yuan Limei, Meng Chenyang, Zhao Tiansuo, Gao Song, Huang Chongbiao, Wang Hongwei, Ma Ying, Zhou Tianxing, Feng Yukuan, Chang Antao, Yang Chao, Yu Jun, Yu Wenwen, Zang Fenglin, Zhang Yanhui, Ji Ru-Rong, Wang Xiuchao, Hao Jihui
神经科学
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma

CD147靶向小分子抑制剂通过诱导胰腺导管腺癌中的铁死亡来增强吉西他滨的疗效

期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2025.102292
Jiaqi Li,Chaozhe Ma,Pei Cao,Weihua Guo,Pengyu Wang,Yang Yang,Bowen Ding,Fengyi Yin,Zhe Li,Yifei Wang,Shouyi Li,Chongbiao Huang,Xiuchao Wang,Tianxing Zhou,Antao Chang,Liang Zhao,Song Gao,Tiansuo Zhao,Hongwei Wang,Jun Yu,Jingyuan Xu,Yukuan Feng,Jihui Hao
胰腺癌
肿瘤
CD14
CD147
铁死亡
发表日期：2025
文献求助 收藏

Risk Stratification and Prognosis Determination Based on Protein Lysine Crotonylation in Patients with Resected Pancreatic Cancer: A Multicenter Study

基于蛋白质赖氨酸巴豆酰化对胰腺癌切除患者进行风险分层和预后判断：一项多中心研究

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-4300
Cao, Lianjing; Li, Huaxin; Liu, Fang; Zhao, Tiansuo; Shi, Xiaoya; Liu, Han; Sun, Yan; Wei, Feng; Ren, He
巴豆酰化
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters

胰腺癌综合预处理分层系统：结合解剖可切除性和肿瘤生物学参数

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2025.0213
Gao, Song; Liang, Yuexiang; Yu, Jun; Chang, Shaofei; Wang, Hongwei; Zhao, Tiansuo; Wang, Xiuchao; Man, Quan; Li, Zhifei; Zou, Yiping; Jiang, Kuirong; Gao, Chuntao; Hao, Jihui
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

CLT-003 通过阻断 PI3K/AKT/HIF-1α 通路发挥抗胰腺癌的活性。

期刊:Cancer Biology & Medicine
影响因子:8.4
doi:10.20892/j.issn.2095-3941.2025.0058
Xu Chao, Li Zekun, Shan Yueying, She Chunhua, Yang Yanfang, Zhou Tianxing, Xie Yongjie, Ni Bo, Meng Chenyang, Shen Guangcong, Fu Boyang, Sheng Guannan, Wu Liangliang, Pei Jinlong, Zhao Tiansuo, Gao Song, Wang Hongwei, Deng Chengqi, Wang Kaiyuan, Chang Antao, Huang Chongbiao, Shi Lei, Yang Shengyu, Yu Jun, Hao Jihui, Wang Xiuchao
胰腺癌
信号转导
AKT
PI3K/Akt
发表日期：2025
文献求助 收藏

BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism

BICC1通过促进色氨酸代谢来驱动胰腺癌干细胞特性和化疗耐药性。

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.adj8650
Sun, Huizhi; Li, Hui; Guan, Yuqi; Yuan, Yudong; Xu, Chao; Fu, Danqi; Xie, Peng; Li, Jianming; Zhao, Tiansuo; Wang, Xiuchao; Feng, Yukuan; Wang, Hongwei; Gao, Song; Yang, Shengyu; Shi, Yi; Liu, Jing; Chang, Antao; Huang, Chongbiao; Hao, Jihui
肿瘤
胰腺癌
细胞生物学
肿瘤免疫
代谢
干细胞
发育与干细胞
发表日期：2024
文献求助 收藏

BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

BICC1通过诱导不依赖于VEGF的血管生成来促进胰腺癌的进展。

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-023-01478-5
Huang, Chongbiao; Li, Hui; Xu, Yang; Xu, Chao; Sun, Huizhi; Li, Zengxun; Ge, Yi; Wang, Hongwei; Zhao, Tiansuo; Gao, Song; Wang, Xiuchao; Yang, Shengyu; Sun, Peiqing; Liu, Zhe; Liu, Jing; Chang, Antao; Hao, Jihui
肿瘤
胰腺癌
肿瘤免疫
EGF
VEGF
血管生成
发表日期：2023
文献求助 收藏

Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

厄贝沙坦通过抑制 Hippo/YAP1/c-Jun 轴来抑制干细胞和铁代谢，从而克服胰腺癌对吉西他滨的耐药性

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-023-02671-8
Tianxing Zhou #, Yongjie Xie #, Xupeng Hou #, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan, Zhaoyu Zhang, Yifei Wang, Hongwei Wang, Wenna Jiang, Song Gao, Tiansuo Zhao, Antao Chang, Xiuchao Wang, Hongxia Sun, Xiufeng Zhang, Shengyu Yang, Chongbiao Huang, Jihui Hao,
代谢
信号转导
发育与干细胞
肿瘤
胰腺癌
干细胞
Hippo
发表日期：2023
文献求助 收藏

Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I-III pancreatic ductal adenocarcinoma: a retrospective cohort study

新辅助治疗后行根治性切除术与直接手术治疗I-III期胰腺导管腺癌的生存结局：一项回顾性队列研究

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000425
Zou, Yiping; Gao, Song; Yu, Xin; Zhou, Tianxing; Xie, Yongjie; Guo, Xiaofan; An, Ran; Wang, Xiuchao; Zhao, Tiansuo; Chang, Antao; Gao, Chuntao; Yu, Jun; Hao, Jihui
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏